0 Comments
Lymphoma – A Basic Understanding |
|
The first day on August is observed as the World Lung Cancer Day to raise awareness about the impact of lung cancer. In connection to the World Lung Cancer Day, we present an infographic depicting the burden of Lung cancer in the APAC region. |
Promotional Messaging Support for a Scandinavian Medical Device Company
(Focus: APAC)
A Scandinavian medical device company entering the APAC market, needed support in choosing the content for promotional messaging, for its newly launched Point of Care (PoC) device. Read more to know how we helped our client with this problem.
Real-World Data and Real-World Evidence: Current status in the APAC region
(Focus: India)
In the third interview of our the Real-World Data series, our analyst Shilna Kunnath connected with Dr. Randeep Singh, Director Medical Oncologist, Narayana Hospitals and Oncomed Clinic, Delhi/NCR to discuss about the current status of Real-world Data usage in India.
... real-world data is helpful in clinical evaluation of rare diseases where conducting regular controlled trials is not feasible.
Conference Impact Assessment of Global Medical Device Company
(Focus: APAC)
Background: Our US-based client, with a portfolio of cardiology/oncology interventional medical devices, planned to understand brand awareness among customers by hosting a conference.
Real-World Data and Real-World Evidence: Current status in the APAC region
(Focus: Singapore)
In the second post of the interview series, our team members, Raja Mukesh Dokala, Senior Manager and Khusnuma Begum, Senior Analyst discussed the current status of RWD in Singapore with Prof Teo Eng Kiong, HoD, Department of Gastroenterology and Chairman, Medical Board, Changi General Hospital, Singapore.
Real world data is essential because it reflects what really happens! It also helps us track how many patients cannot afford it (an expensive therapy) and what percent actually gets successfully treated.
Real-World Data and Real-World Evidence: Current status in the APAC region
(Focus: Australia)
The use of real-world data (RWD) to supplement randomized clinical trials has been a growing trend recently. Several companies started using RWD to make informed pricing and reimbursement decisions and are also exploring other ways to use RWD in developing their clinical pipeline. At the same time, several countries are deliberating on how to employ real-world evidence (RWE) in their drug approval process.
... Australia or anywhere else the biggest problem now is noise in the data.